1. Home
  2. CMPX vs CPAC Comparison

CMPX vs CPAC Comparison

Compare CMPX & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.42

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$10.66

Market Cap

848.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPX
CPAC
Founded
2014
1949
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
927.5M
848.5M
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
CMPX
CPAC
Price
$2.42
$10.66
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$14.57
$12.90
AVG Volume (30 Days)
6.0M
16.7K
Earning Date
05-06-2026
04-24-2026
Dividend Yield
N/A
5.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.49
Revenue Next Year
$934.41
N/A
P/E Ratio
N/A
$19.78
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$5.66
52 Week High
$6.88
$11.50

Technical Indicators

Market Signals
Indicator
CMPX
CPAC
Relative Strength Index (RSI) 44.72 45.59
Support Level $1.68 $10.32
Resistance Level $3.82 $10.88
Average True Range (ATR) 0.17 0.20
MACD 0.19 -0.02
Stochastic Oscillator 92.35 26.32

Price Performance

Historical Comparison
CMPX
CPAC

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: